The promise and challenges of deep learning models for automated histopathologic classification and mutation prediction in lung cancer

被引：7

作者：

Patil, Pradnya D. ^{[1
]}

Hobbs, Brian ^{[2
]}

Pennell, Nathan A. ^{[1
]}

机构：

[1] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Oncol, 9500 Euclid Ave,CA-6, Cleveland, OH 44195 USA

[2] Cleveland Clin, Taussig Canc Inst, Dept Quantitat Hlth Sci, Cleveland, OH 44195 USA

来源：

JOURNAL OF THORACIC DISEASE | 2019年 / 11卷 / 02期

关键词：

CONVOLUTIONAL NEURAL-NETWORKS;

D O I：

10.21037/jtd.2018.12.55

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：369 / 372

页数：4

共 14 条

[1]

Abels Esther, 2017, J Pathol Inform, V8, P23, DOI 10.4103/jpi.jpi_11_17

[2]

[Anonymous], LECT NOTES COMPUTER

[3] Classification and mutation prediction from non-small cell lung cancer histopathology images using deep learning [J].

Coudray, Nicolas ;

Ocampo, Paolo Santiago ;

Sakellaropoulos, Theodore ;

Narula, Navneet ;

Snuderl, Matija ;

Fenyo, David ;

Moreira, Andre L. ;

Razavian, Narges ;

Tsirigos, Aristotelis .

NATURE MEDICINE, 2018, 24 (10) :1559-+

[4] Deep Convolutional Neural Networks Enable Discrimination of Heterogeneous Digital Pathology Images [J].

Khosravi, Pegah ;

Kazemi, Ehsan ;

Imielinski, Marcin ;

Elemento, Olivier ;

Hajirasouliha, Iman .

EBIOMEDICINE, 2018, 27 :317-328

[5] Clinicopathologic characteristics of EGFR, KRAS, and ALK alterations in 6,595 lung cancers [J].

Lee, Boram ;

Lee, Taebum ;

Lee, Se-Hoon ;

Choi, Yoon-La ;

Han, Joungho .

ONCOTARGET, 2016, 7 (17) :23874-23884

[6] Biomarker testing and time to treatment decision in patients with advanced nonsmall-cell lung cancer [J].

Lim, C. ;

Tsao, M. S. ;

Le, L. W. ;

Shepherd, F. A. ;

Feld, R. ;

Burkes, R. L. ;

Liu, G. ;

Kamel-Reid, S. ;

Hwang, D. ;

Tanguay, J. ;

Santos, G. da Cunha ;

Leighl, N. B. .

ANNALS OF ONCOLOGY, 2015, 26 (07) :1415-1421

[7] Timeliness of care in patients with lung cancer: a systematic review [J].

Olsson, J. K. ;

Schultz, E. M. ;

Gould, M. K. .

THORAX, 2009, 64 (09) :749-756

[8]

Rawat W, 2017, NEURAL COMPUT, V29, P2352, DOI [10.1162/neco_a_00990, 10.1162/NECO_a_00990]

[9]

Sandler A, 2007, NEW ENGL J MED, V356, P318

[10] Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer [J].

Scagliotti, Giorgio Vittorio ;

Parikh, Purvish ;

von Pawel, Joachim ;

Biesma, Bonne ;

Vansteenkiste, Johan ;

Manegold, Christian ;

Serwatowski, Piotr ;

Gatzemeier, Ulrich ;

Digumarti, Raghunadharao ;

Zukin, Mauro ;

Lee, Jin S. ;

Mellemgaard, Anders ;

Park, Keunchil ;

Patil, Shehkar ;

Rolski, Janusz ;

Goksel, Tuncay ;

de Marinis, Filippo ;

Simms, Lorinda ;

Sugarman, Katherine P. ;

Gandara, David .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3543-3551

← 1 2 →